Marqeta Down 1.3% as Peers Rally Into Earnings Day

MQ fell 1.3% over the past week while its closest payment-processing peers gained a median of 5.8%. FIS added 8.9%, FISV 7.4%, and PYPL 6.9% across the same period. The gap is stark. MQ closed Monday at $17.80, then dropped a further 4.4% on Tuesday, leaving it adrift from a sector that has been moving firmly higher.

Options positioning has swung toward call-side optimism rather than defensive hedging. The put/call ratio has dropped to 0.58, more than one standard deviation below its 20-day average of 0.71, the most call-heavy reading in several weeks. That shift is a reversal from late September, when the ratio topped 1.7. At the same time, borrow conditions offer no meaningful resistance to either side: short interest is just 1.0% of the free float, down 13% over the past month, and availability is exceptionally loose at 4,728%, meaning the lending market is not a constraint on positioning. Cost to borrow at 0.43% is negligible. The ORTEX short score has drifted lower from 42.1 to 40.8 over the past two weeks, a mild directional signal consistent with shorts reducing exposure rather than adding.

The fundamental debate centres on whether Marqeta's gross profit engine can remain insulated from revenue line pressure. Management cut its 2025 net revenue outlook due to accounting changes from a renegotiated platform partnership, but maintained gross profit guidance, which is the number the company has asked investors to watch. The bear concern is deceleration from key BNPL clients as year-over-year comparisons tighten and new customer ramp times remain long. The bull case leans on the card-issuing platform's first-mover advantages with partners such as Block, DoorDash, and Klarna, alongside EPS estimate momentum that ranks in the 97th and 99th percentiles for surprise and 90-day momentum respectively. Analyst targets cluster near $20.65, implying roughly 16% upside from Monday's close, though the most recent substantive moves from Keefe Bruyette and Morgan Stanley, both in mid-2026, kept neutral-equivalent ratings in place. The Morgan Stanley target revision in July deserves a note of caution: it moved from $5 to $20, a large step that may reflect a share restructuring or unit change rather than a pure valuation call, so that figure should be treated carefully.

Insider activity has been routine rather than directional. The net 90-day flow across open-market transactions is a disposal of roughly $55,000 in value, almost entirely small scheduled sales under pre-arranged 10b5-1 plans by Crystal Sumner and director Martha Cummings. Founder Jason Gardner exercised options on 270,000 shares in September, but no cash transaction was recorded. The CEO, Michael Milotich, exercised and withheld shares in September as part of standard vesting, also not an open-market signal. T. Rowe Price remains the largest institutional holder at 17% of shares, with BlackRock at 6.6%. Dimensional Fund Advisors cut its disclosed stake from 8% to 2% in filings between July and October, a material reduction worth monitoring, though as with all 13G disclosures the position reflects the last filing date and may have changed further since.

The print tonight will test whether gross profit growth holds its trajectory independently of the revenue line, and whether management's confidence in that separation is enough to close the week's performance gap against peers that have already moved.